1 |
Walsh JP. Managing thyroid disease in general practice [J]. Med J Aust, 2016, 205(4): 179-184.
|
2 |
Li Y, Teng D, Ba J, et al. Efficacy and safety of long-term universal salt iodization on thyroid disorders: epidemiological evidence from 31 provinces of mainland China [J]. Thyroid, 2020, 30(4): 568-579.
|
3 |
中华医学会超声医学分会浅表器官和血管学组, 中国甲状腺与乳腺超声人工智能联盟. 2020甲状腺结节超声恶性危险分层中国指南: C-TIRADS [J]. 中华超声影像学杂志, 2021, 30(3): 185-200.
|
4 |
Durante C, Grani G, Lamartina L, et al. The diagnosis and management of thyroid nodules: a review [J]. JAMA, 2018, 319(9): 914-924.
|
5 |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J]. Thyroid, 2016, 26(1): 131-133.
|
6 |
Zhu H, Yang Y, Wu S, et al. Diagnostic performance of US-based FNAB criteria of the 2020 Chinese guideline for malignant thyroid nodules: comparison with the 2017 American College of Radiology guideline, the 2015 American Thyroid Association guideline, and the 2016 Korean Thyroid Association guideline [J]. Quant Imaging Med Surg, 2021, 11(8): 3604-3618.
|
7 |
Wang Y, Lei KR, He YP, et al. Malignancy risk stratification of thyroid nodules: comparisons of four ultrasound thyroid imaging reporting and data systems in surgically resected nodules [J]. Sci Rep, 2017, 7(1): 11560.
|
8 |
Luo W, Yang X, Yuan J, et al. Evaluation of characteristics of thyroid nodules on contrast-enhanced ultrasonography: a retrospective analysis of 252 cases [J]. Med Ultrason, 2020, 22(2): 164-170.
|
9 |
Zhang P, Liu H, Yang X, et al. Comparison of contrast-enhanced ultrasound characteristics of inflammatory thyroid nodules and papillary thyroid carcinomas using a quantitative time-intensity curve: a propensity score matching analysis [J]. Quant Imaging Med Surg, 2022, 12(11): 5209-5221.
|
10 |
韩鹏, 费翔, 罗渝昆, 等. 高帧频超声造影在鉴别诊断胆囊腺瘤性息肉与胆固醇性息肉中的临床应用 [J/OL]. 中华医学超声杂志(电子版), 2020, 17(9): 815-820.
|
11 |
Diao X, Zhan J, Chen L, et al. Quantification of solid hypo-echoic thyroid nodule enhancement with contrast-enhanced ultrasound [J]. Transl Cancer Res, 2017, 6(6): 1078-1087.
|
12 |
Ma JJ, Sun M, Tian Y, et al. Values of the quantitative parameters of contrast-enhanced ultrasound in the diagnosis of thyroid benign and malignant nodules [J]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2020, 42(1): 80-85.
|
13 |
Ruan J, Xu X, Cai Y, et al. A practical CEUS thyroid reporting system for thyroid nodules [J]. Radiology, 2022, 305(1): 149-159.
|
14 |
Brandenstein M, Wiesinger I, Künzel J, et al. Multiparametric sonoimagedata imaging of thyroid lesions: chances of b-mode, elastography and CEUS in relation to preoperative histopathology [J]. Cancers (Basel), 2022, 14(19): 4745.
|
15 |
Sidhu PS, Cantisani V, Dietrich CF, ea al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (short version) [J]. Ultraschall Med, 2018, 39(2): 154-180.
|
16 |
Sorrenti S, Dolcetti V, Fresilli D, et al. The role of CEUS in the evaluation of thyroid cancer: from diagnosis to local staging [J]. J Clin Med, 2021, 10(19): 4559.
|
17 |
Gu F, Han L, Yang X, et al. Value of time-intensity curve analysis of contrast-enhanced ultrasound in the differential diagnosis of thyroid nodules [J]. Eur J Radiol, 2018, 105: 182-187.
|
18 |
Wu Q, Wang Y, Li Y, et al. Diagnostic value of contrast-enhanced ultrasound in solid thyroid nodules with and without enhancement [J]. Endocrine, 2016, 53(2): 480-488.
|